Detalles de la búsqueda
1.
Mismatched related donor allogeneic haematopoietic cell transplantation compared to other donor types for Ph+ chronic myeloid leukaemia: A retrospective analysis from the Chronic Malignancies Working Party of the EBMT.
Br J Haematol
; 204(6): 2365-2377, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38577874
2.
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
Mod Pathol
; 37(2): 100406, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38104892
3.
Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.
Am J Hematol
; 99(6): 1172-1174, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436141
4.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood
; 138(21): 2042-2050, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407543
5.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood
; 138(21): 2031-2041, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407542
6.
Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors: A retrospective study by the chronic malignancies working party of the EBMT.
Am J Hematol
; 98(1): 112-121, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36266607
7.
Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity.
Nature
; 541(7635): 81-86, 2017 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28002404
8.
Assessment of quantitative polymerase chain reaction for BCR-ABL1 transcripts in chronic myeloid leukaemia: Are improved outcomes in patients with e14a2 transcripts an artefact of technology?
Br J Haematol
; 197(1): 52-62, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997766
9.
Measurable residual disease in chronic myeloid leukemia.
Haematologica
; 107(12): 2794-2809, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453517
10.
A retrospective observational research study to describe the real-world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands.
Eur J Haematol
; 109(1): 90-99, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35403752
11.
Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia.
Am J Hematol
; 97(11): 1419-1426, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36054756
12.
TKI dose reduction can effectively maintain major molecular remission in patients with chronic myeloid leukaemia.
Br J Haematol
; 193(2): 346-355, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368155
13.
Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy.
Br J Haematol
; 192(1): 137-145, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022753
14.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580608
15.
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Blood
; 132(4): 393-404, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567798
16.
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond.
Biol Blood Marrow Transplant
; 25(12): 2322-2329, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31071457
17.
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.
Br J Haematol
; 185(1): 89-92, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30637732
18.
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
Blood
; 129(11): 1548-1556, 2017 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-27965196
19.
MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia.
Haematologica
; 104(11): 2206-2214, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30923102
20.
Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.
Haematologica
; 104(12): 2400-2409, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31073075